Abstract:
Introduction.
Currently, there is a certain wave of interest for therapy and prophylaxis with
medicines containing silver, which manifests antimicrobial actions, lack of
resistance to some pathogenic microorganisms and is well tolerated by patients. Of
particular interest is cluster silver (nano-silver).
Purpose.
The study of contemporary aspects in the technology of medicines containing silver.
Material and methods.
Study, analysis of bibliographic sources in the field of nanotechnology of silver
pharmaceutical forms.
Results.
Currently, on the pharmaceutical market there are classic medicines containing, an
improved form of colloidal silver is the "cluster" or nanoparticle type, which is
used in nanotechnology. A substance in the form of nanoparticles has different
properties, small size, provides an extremely large specific surface area that
increases the contact area of silver with bacteria or viruses, significantly improving
their bactericidal action. Thus the use of colloidal nano-silver makes it possible to
reduce the concentration of silver, while maintaining the therapeutic properties.
Conclusions.
The elaboration of medicines containing solid silver of cluster type or nanoparticles
allows to increase the efficacy of pharmacotherapy.
